gdme0220rdb - asia-pacific drug delivery devices market ... · this report is a licensed product...

SAMPLE

Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous

Catheters and Others GDME0220RDB / Published January 2013

© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form

Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others

Reference Code: GDME0220RDB

Publication Date: January 2013

SAMPLETable of Contents




1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 8

1.2 List of Figures 9

2 Introduction 11

2.1 What is This Report About? 11

3 Drug Delivery Devices in Asia-Pacific 12

3.1 Drug Delivery Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 12

3.2 Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018 13

3.3 Drug Delivery Devices, Asia-Pacific, Company share (2010-2011) 19

4 Drug Delivery Devices In Japan 21

4.1 Drug Delivery Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 21

4.2 Drug Delivery Devices, Japan, Distribution Share (2010-2011) 27 4.2.1 Central Venous Catheters, Japan, Distribution Share (2010-2011) 27 4.2.2 Infusion Systems, Japan, Distribution Share (2010-2011) 27 4.2.3 Metered Dose Inhaler Devices, Japan, Distribution Share (2010-2011) 28 4.2.4 Needle Free Injections, Japan, Distribution Share (2010-2011) 28

4.3 Drug Delivery Devices, Japan, Company Share (2010-2011) 29 4.3.1 Drug Delivery Devices, Japan, Company Share (2010-2011) 29 4.3.2 Central Venous Catheters, Japan, Company Share (2010-2011) 31 4.3.3 Infusion Systems, Japan, Company Share (2010-2011) 33 4.3.4 Metered Dose Inhaler Devices, Japan, Company Share (2010-2011) 35 4.3.5 Needle Free Injections, Japan, Company Share (2010-2011) 36

5 Drug Delivery Devices In Australia 37

5.1 Drug Delivery Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 37

5.2 Drug Delivery Devices, Australia, Distribution Share (2010-2011) 43





5.2.1 Central Venous Catheters, Australia, Distribution Share (2010-2011) 43 5.2.2 Infusion Systems, Australia, Distribution Share (2010-2011) 43 5.2.3 Metered Dose Inhaler Devices, Australia, Distribution Share (2010-2011) 44 5.2.4 Needle Free Injections, Australia, Distribution Share (2010-2011) 44

5.3 Drug Delivery Devices, Australia, Company Share (2010-2011) 45 5.3.1 Drug Delivery Devices, Australia, Company Share (2010-2011) 45 5.3.2 Central Venous Catheters, Australia, Company Share (2010-2011) 47 5.3.3 Infusion Systems, Australia, Company Share (2010-2011) 49 5.3.4 Metered Dose Inhaler Devices, Australia, Company Share (2010-2011) 51 5.3.5 Needle Free Injections, Australia, Company Share (2010-2011) 52

6 Drug Delivery Devices In China 53

6.1 Drug Delivery Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 53

6.2 Drug Delivery Devices, China, Distribution Share (2010-2011) 58 6.2.1 Central Venous Catheters, China, Distribution Share (2010-2011) 58 6.2.2 Infusion Systems, China, Distribution Share (2010-2011) 58 6.2.3 Metered Dose Inhaler Devices, China, Distribution Share (2010-2011) 59 6.2.4 Needle Free Injections, China, Distribution Share (2010-2011) 59

6.3 Drug Delivery Devices, China, Company Share (2010-2011) 60 6.3.1 Drug Delivery Devices, China, Company Share (2010-2011) 60 6.3.2 Central Venous Catheters, China, Company Share (2010-2011) 62 6.3.3 Infusion Systems, China, Company Share (2010-2011) 64 6.3.4 Metered Dose Inhaler Devices, China, Company Share (2010-2011) 66 6.3.5 Needle Free Injections, China, Company Share (2010-2011) 67

7 Drug Delivery Devices In India 68

7.1 Drug Delivery Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 68

7.2 Drug Delivery Devices, India, Distribution Share (2010-2011) 73 7.2.1 Central Venous Catheters, India, Distribution Share (2010-2011) 73 7.2.2 Infusion Systems, India, Distribution Share (2010-2011) 73 7.2.3 Metered Dose Inhaler Devices, India, Distribution Share (2010-2011) 74 7.2.4 Needle Free Injections, India, Distribution Share (2010-2011) 74

7.3 Drug Delivery Devices, India, Company Share (2010-2011) 75 7.3.1 Drug Delivery Devices, India, Company Share (2010-2011) 75 7.3.2 Central Venous Catheters, India, Company Share (2010-2011) 77 7.3.3 Infusion Systems, India, Company Share (2010-2011) 79





7.3.4 Metered Dose Inhaler Devices, India, Company Share (2010-2011) 81 7.3.5 Needle Free Injections, India, Company Share (2010-2011) 83

8 Overview of Key Companies in Asia-Pacific Drug Delivery Devices Market 84

8.1 GlaxoSmithKline plc 84 8.1.1 Company Overview 84 8.1.2 Share in the Asia-Pacific Drug Delivery Devices Market 84

8.2 Boehringer Ingelheim GmbH 85 8.2.1 Company Overview 85 8.2.2 Share in the Asia-Pacific Drug Delivery Devices Market 85

8.3 AstraZeneca PLC 86 8.3.1 Company Overview 86 8.3.2 Share in the Asia-Pacific Drug Delivery Devices Market 86

8.4 Terumo Corporation 87 8.4.1 Company Overview 87 8.4.2 Share in the Asia-Pacific Drug Delivery Devices Market 87

8.5 Nipro Corporation 88 8.5.1 Company Overview 88 8.5.2 Share in the Asia-Pacific Drug Delivery Devices Market 88

8.6 Baxter International Inc. 89 8.6.1 Company Overview 89 8.6.2 Share in the Asia-Pacific Drug Delivery Devices Market 89

8.7 JMS Co., Ltd. 90 8.7.1 Company Overview 90

8.8 CareFusion Corporation 90 8.8.1 Company Overview 90

8.9 Hospira, Inc. 91 8.9.1 Company Overview 91

8.10 Smiths Medical 91 8.10.1 Company Overview 91

8.11 B. Braun Melsungen AG 91 8.11.1 Company Overview 91





8.12 Fresenius Kabi AG 92 8.12.1 Company Overview 92

8.13 3M Health Care Ltd. 92 8.13.1 Company Overview 92

8.14 Medtronic, Inc. 92 8.14.1 Company Overview 92

8.15 Teleflex Incorporated 93 8.15.1 Company Overview 93

8.16 Sunovion Pharmaceuticals Inc. 93 8.16.1 Company Overview 93

8.17 Daiken Medical Co., Ltd. 94 8.17.1 Company Overview 94

8.18 C. R. Bard, Inc. 94 8.18.1 Company Overview 94

8.19 TOP Corporation 94 8.19.1 Company Overview 94

8.20 Edwards Lifesciences Corporation 95 8.20.1 Company Overview 95

8.21 Becton, Dickinson and Company 95 8.21.1 Company Overview 95

8.22 Bioject Medical Technologies Inc. 96 8.22.1 Company Overview 96

8.23 INJEX - Equidyne Systems 96 8.23.1 Company Overview 96

8.24 Consort Medical plc 96 8.24.1 Company Overview 96

8.25 Antares Pharma, Inc. 97 8.25.1 Company Overview 97

8.26 Trivitron Healthcare Pvt Ltd. 97 8.26.1 Company Overview 97





8.27 Cipla Ltd. 98 8.27.1 Company Overview 98

9 Drug Delivery Devices Market Pipeline Products 99

10 Financial Deals Landscape 105

10.1 Acquisition 105 10.1.1 Imugene Completes Acquisition Of Lingual Consegna From Consegna Group 105 10.1.2 Consegna Acquires Remaining 19% Stake In Leading Edge Instruments For $8 Million 107

10.2 Partnerships 108 10.2.1 Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System 108 10.2.2 Claris Lifesciences Enters Into Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business 109 10.2.3 Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology 111 10.2.4 Echo Therapeutics Expands Licensing Agreement With Ferndale Pharma 112 10.2.5 Arte Enters Into Co-Development Agreement With ProJect Pharma 113

11 Recent Developments 114

11.1 Strategy And Business Planning 114 11.1.1 Oct 08, 2012: Dr. Reddy’s Custom Pharmaceutical Services Business Expands Manufacturing Operations In Mirfield, UK 114 11.1.2 Apr 05, 2012: Owen Mumford Establishes New Office In China 114 11.1.3 Mar 21, 2012: GE Healthcare Expands Shanghai Fast Track Training Center To Serve Biopharmaceutical Industry In China 115 11.1.4 Jan 24, 2012: Aptar pharma Opens New Facility In India 115

11.2 Legal and Regulatory 116 11.2.1 Aug 22, 2012: Indian Supreme Court To Hear Novartis Plea In Glivec Patent Case From Sept 11 116

11.3 Product News 116 11.3.1 Mar 26, 2010: Milestone Forms Alliance With Sinopharm For SFDA Approval Of STA System 116 11.3.2 Jan 28, 2008: BioSphere Medical Receives Market Clearance To Sell Embosphere Microspheres In The People's Republic Of China 117

12 Appendix 118

12.1 Definitions of Markets Covered in the Report 119





12.1.1 Drug Delivery Devices 119

12.2 Research Methodology 120

12.3 Secondary Research 120

12.4 Primary Research 120

12.5 Models 121

12.6 Forecasts 121

12.7 Expert Panels 121

12.8 GlobalData Consulting 122

12.9 Currency Conversion 122

12.10 Disclaimer 122





1.1 List of Tables Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 ..................... 12

Table 2: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018................................. 13

Table 3: Drug Delivery Devices, Asia-Pacific, Cross-Category Analysis, 2004-2018 ...................................................... 14

Table 4: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011 .................. 16

Table 5: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ................ 18

Table 6: Drug Delivery Devices, Asia-Pacific, Company share by Revenue ($m), USD Constant, 2010-2011 ............. 20

Table 7: Drug Delivery Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 .......................................... 22

Table 8: Drug Delivery Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ........................... 24

Table 9: Drug Delivery Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ......................... 26

Table 10: Central Venous Catheters, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ........... 27

Table 11: Infusion Systems, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ......................... 27

Table 12: Metered Dose Inhaler Devices, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011.... 28

Table 13: Needle Free Injections, Japan, Distribution Share by Revenue ($m), USD Constant, 2010-2011................. 28

Table 14: Drug Delivery Devices, Japan, Company Share, USD Constant, (2010-2011) ............................................... 30

Table 15: Central Venous Catheters, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011.............. 32

Table 16: Infusion Systems, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 ............................ 34

Table 17: Metered Dose Inhaler Devices, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 ...... 35

Table 18: Needle Free Injections, Japan, Company Share by Revenue ($m), USD Constant, 2010-2011 ................... 36

Table 19: Drug Delivery Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 ................................... 38

Table 20: Drug Delivery Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ..................... 40

Table 21: Drug Delivery Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ................... 42

Table 22: Central Venous Catheters, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011....... 43

Table 23: Infusion Systems, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ..................... 43

Table 24: Metered Dose Inhaler Devices, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 44

Table 25: Needle Free Injections, Australia, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ............ 44

Table 26: Drug Delivery Devices, Australia, Company Share, USD Constant, (2010-2011)........................................... 46

Table 27: Central Venous Catheters, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 ......... 48

Table 28: Infusion Systems, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 ........................ 50

Table 29: Metered Dose Inhaler Devices, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 .. 51

Table 30: Needle Free Injections, Australia, Company Share by Revenue ($m), USD Constant, 2010-2011 ............... 52

Table 31: Drug Delivery Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 ........................................ 53

Table 32: Drug Delivery Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 .......................... 55

Table 33: Drug Delivery Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ........................ 57

Table 34: Central Venous Catheters, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ........... 58

Table 35: Infusion Systems, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 .......................... 58

Table 36: Metered Dose Inhaler Devices, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 .... 59

Table 37: Needle Free Injections, China, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ................. 59





Table 38: Drug Delivery Devices, China, Company Share, USD Constant, (2010-2011) ............................................... 61

Table 39: Central Venous Catheters, China, Company Share by Revenue ($m), USD Constant, 2010-2011 .............. 63

Table 40: Infusion Systems, China, Company Share by Revenue ($m), USD Constant, 2010-2011 ............................. 65

Table 41: Metered Dose Inhaler Devices, China, Company Share by Revenue ($m), USD Constant, 2010-2011 ....... 66

Table 42: Needle Free Injections, China, Company Share by Revenue ($m), USD Constant, 2010-2011 .................... 67

Table 43: Drug Delivery Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 .......................................... 68

Table 44: Drug Delivery Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ........................... 70

Table 45: Drug Delivery Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ......................... 72

Table 46: Central Venous Catheters, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ............. 73

Table 47: Infusion Systems, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011............................ 73

Table 48: Metered Dose Inhaler Devices, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011 ...... 74

Table 49: Needle Free Injections, India, Distribution Share by Revenue ($m), USD Constant, 2010-2011................... 74

Table 50: Drug Delivery Devices, India, Company Share, USD Constant, (2010-2011) ................................................. 76

Table 51: Central Venous Catheters, India, Company Share by Revenue ($m), USD Constant, 2010-2011 ................ 78

Table 52: Infusion Systems, India, Company Share by Revenue ($m), USD Constant, 2010-2011 .............................. 80

Table 53: Metered Dose Inhaler Devices, India, Company Share by Revenue ($m), USD Constant, 2010-2011 ........ 82

Table 54: Needle Free Injections, India, Company Share by Revenue ($m), USD Constant, 2010-2011 ..................... 83

Table 55: Drug Delivery Devices Market Pipeline Products .............................................................................................. 99

Table 56: Imugene Completes Acquisition Of Lingual Consegna From Consegna Group ............................................ 105

Table 57: Consegna Acquires Remaining 19% Stake In Leading Edge Instruments For $8 Million ............................. 107

Table 58: Hospira Enters Into Distribution Agreement With Q Core Medical For Sapphire Infusion System ............... 108

Table 59: Claris Lifesciences Enters Into Joint Venture With Otsuka Pharma Factory And Mitsui For Infusion Business.......................................................................................................................................................................................... 109

Table 60: Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology ...................................... 111

Table 61: Echo Therapeutics Expands Licensing Agreement With Ferndale Pharma .................................................. 112

Table 62: Arte Enters Into Co-Development Agreement With ProJect Pharma ............................................................. 113

1.2 List of Figures Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018................... 12

Figure 2: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018 ............................... 13

Figure 3: Drug Delivery Devices, Asia-Pacific, Cross-Category Analysis, by Revenue ($m), USD Constant, 2004-2018............................................................................................................................................................................................ 14

Figure 4: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ................. 15

Figure 5: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ............... 17

Figure 6: Drug Delivery Devices, Asia-Pacific, Company share (%), 2011 ...................................................................... 19

Figure 7: Drug Delivery Devices, Japan, Overall Revenue ($m), USD Constant, 2004-2018 ......................................... 21

Figure 8: Drug Delivery Devices, Japan, Overall Revenue ($m), USD Constant, Historic, 2004-2011 .......................... 23

Figure 9: Drug Delivery Devices, Japan, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ........................ 25

Figure 10: Drug Delivery Devices, Japan, Company Share (%), 2011 ............................................................................. 29





Figure 11: Central Venous Catheters, Japan, Company Share (%), 2011 ....................................................................... 31

Figure 12: Infusion Systems, Japan, Company Share (%), 2011...................................................................................... 33

Figure 13: Metered Dose Inhaler Devices, Japan, Company Share (%), 2011 ................................................................ 35

Figure 14: Needle Free Injections, Japan, Company Share (%), 2011............................................................................. 36

Figure 15: Drug Delivery Devices, Australia, Overall Revenue ($m), USD Constant, 2004-2018 .................................. 37

Figure 16: Drug Delivery Devices, Australia, Overall Revenue ($m), USD Constant, Historic, 2004-2011 .................... 39

Figure 17: Drug Delivery Devices, Australia, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 .................. 41

Figure 18: Drug Delivery Devices, Australia, Company Share (%), 2011 ......................................................................... 45

Figure 19: Central Venous Catheters, Australia, Company Share (%), 2011................................................................... 47

Figure 20: Infusion Systems, Australia, Company Share (%), 2011 ................................................................................. 49

Figure 21: Metered Dose Inhaler Devices, Australia, Company Share (%), 2011 ........................................................... 51

Figure 22: Needle Free Injections, Australia, Company Share (%), 2011 ........................................................................ 52

Figure 23: Drug Delivery Devices, China, Overall Revenue ($m), USD Constant, 2004-2018 ....................................... 53

Figure 24: Drug Delivery Devices, China, Overall Revenue ($m), USD Constant, Historic, 2004-2011 ........................ 54

Figure 25: Drug Delivery Devices, China, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ...................... 56

Figure 26: Drug Delivery Devices, China, Company Share (%), 2011 ............................................................................. 60

Figure 27: Central Venous Catheters, China, Company Share (%), 2011 ....................................................................... 62

Figure 28: Infusion Systems, China, Company Share (%), 2011 ...................................................................................... 64

Figure 29: Metered Dose Inhaler Devices, China, Company Share (%), 2011 ................................................................ 66

Figure 30: Needle Free Injections, China, Company Share (%), 2011 ............................................................................. 67

Figure 31: Drug Delivery Devices, India, Overall Revenue ($m), USD Constant, 2004-2018 ......................................... 68

Figure 32: Drug Delivery Devices, India, Overall Revenue ($m), USD Constant, Historic, 2004-2011 .......................... 69

Figure 33: Drug Delivery Devices, India, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 ........................ 71

Figure 34: Drug Delivery Devices, India, Company Share (%), 2011 ............................................................................... 75

Figure 35: Central Venous Catheters, India, Company Share (%), 2011 ......................................................................... 77

Figure 36: Infusion Systems, India, Company Share (%), 2011........................................................................................ 79

Figure 37: Metered Dose Inhaler Devices, India, Company Share (%), 2011 .................................................................. 81

Figure 38: Needle Free Injections, India, Company Share (%), 2011 ............................................................................... 83

Figure 39: GlaxoSmithKline plc, Company Share (%), Asia-Pacific Drug Delivery Devices Market, 2011..................... 84

Figure 40: Boehringer Ingelheim GmbH, Company Share (%), Asia-Pacific Drug Delivery Devices Market, 2011....... 85

Figure 41: AstraZeneca PLC, Company Share (%), Asia-Pacific Drug Delivery Devices Market, 2011 ........................ 86

Figure 42: Terumo Corporation, Company Share (%), Asia-Pacific Drug Delivery Devices Market, 2011..................... 87

Figure 43: Nipro Corporation, Company Share (%), Asia-Pacific Drug Delivery Devices Market, 2011 ........................ 88

Figure 44: Baxter International Inc., Company Share (%), Asia-Pacific Drug Delivery Devices Market, 2011 .............. 89

SAMPLEIntroduction




2 Introduction GlobalData’s medical equipment market reports are ideal guide for anyone wishing to understand their market better in terms of revenue, distribution share and company share.

2.1 What is This Report About? Asia-Pacific drug delivery devices report provides an overview and the following information:

1. Comprehensive data related to the market revenue, company share and distribution share. 2. Global corporate-level profiles of key companies operating in the drug delivery devices

market in Asia-Pacific. The profile includes a brief overview of the company. The selection of the companies is based on their operational presence in Asia-Pacific. This includes key multinationals as well as key local players.

3. A list of key products under development by different companies. The selection of this list is based on the territory in which these products are being clinically investigated.

Note: “Asia-Pacific;” comprises the following countries – Japan, Australia, China and India.

SAMPLEAsia-Pacific Drug Delivery Devices




3 Drug Delivery Devices in Asia-Pacific

3.1 Drug Delivery Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018

Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018

Source: GlobalData

Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018

Country Name 2004 2011 2018 CAGR 04-11 CAGR 11-18 CAGR 04-18

Source: GlobalData

SAMPLEAsia-Pacific Drug Delivery Devices




3.2 Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018

Figure 2: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018

Source: GlobalData

Table 2: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), USD Constant, 2004-2018

Category 2004 2011 2018 CAGR 04-11 CAGR 11-18 CAGR 04-18

Source: GlobalData

SAMPLEAppendix



© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form Page 118

12 Appendix The data and analysis within this report is driven by Medical eTrack

Medical eTrack gives you the key information to drive sales, investment and deal making activity in your business. It includes the following information:

15,000+ Market size data tables across 740 medical equipment segments and 39 countries with historic data from 2004 forecast to 2018

6,000+ Primary expert interviews conducted per annum for ensuring data and report quality

1,100+ Conferences on medical equipment covered

1,000+ Industry leading reports per annum covering growing sectors, market trends, investment opportunities and competitive landscape

600+ Analysis reports covering market and pipeline product analysis reports by indication, medical equipment trends and issue reports and investment and M&A trend reports worth over $3 Million

43,000+ Medical equipment companies profiled

1,500+ Private, emerging and technology start-up company profiles

1,500+ Medical equipment manufacturers in China and India

1,500+ Medical equipment companies in Japan

700+ Companies with revenue splits and market shares by category

1,500+ Quarterly and annual medical equipment company financials

700+ Medical equipment company SWOT’s

9,000+ Pipeline product profiles

8,000+ Marketed product profiles

14,000+ Clinical trials

15,000+ Trial investigators

13,000+ New product patents

3,300+ Companies with products in development

17,000+ Deals in the medical equipment industry 1,100+ Surgical and diagnostic procedures by therapy area

40+ Key healthcare indicators by country o For more information or to receive a free demo of the service visit

http://www.medicaletrack.com/contactus.aspx?RD=Demo=

SAMPLEAppendix




12.1 Definitions of Markets Covered in the Report 12.1.1 Drug Delivery Devices

Drug delivery devices are used for administration of drug compounds in effective ways. They include both hospital and home care devices. Metered dose inhaler devices, central venous catheters, needle free injections and infusion systems are tracked under this market.

12.1.1.1 Central Venous Catheters

A central venous catheter is a long, thin, flexible tube used to administer medicines, fluids, nutrients, or blood products and to monitor haemodynamic status of the patients in surgical and critical care settings over a long period of time, usually several weeks or more. These come in different sizes. Antimicrobial & Non antimicrobial central venous catheters are included under this category.

12.1.1.2 Infusion Systems

Infusion systems are used to administer medication to a patient in critical care, emergency care, home care and trauma centres. Volumetric pumps, syringe pumps, ambulatory infusion pumps, implantable infusion pumps and infusion disposable sets are tracked under this category.

12.1.1.3 Metered Dose Inhaler Devices

Metered dose inhaler devices deliver a specific amount of medication to the lungs. A metered-dose inhaler consists of a canister, the metering valve and an actuator.

12.1.1.4 Needle Free Injections

Needle-free Injections are the devices that do not use a needle to administer medication. They propel a small jet of liquid or powder at high speed through a microscopic orifice causing it to penetrate the skin for subcutaneous, intra-dermal, or intramuscular administration. Disposable needle free syringes are not tracked in this category. Needle free injection comprises of three parts - durable injector, disposable vial adapter and needle free syringes. Disposable components like vial adapters and syringes that come only with the first purchase of needle free syringe system is tracked and disposable components for subsequent use of the injectors are not tracked. Pre filled needle-free injections are not covered under this category. One unit refers to one needle free injection.

Note: 1). Value, distribution and company shares figures reflect annual gross sales of drug delivery devices in local currency converted to $ at constant rate. The annual growth (year on year growth) and compounded annual growth rate (CAGR) in tables is rounded off to one decimal place.

2). Company share data represents market share (in revenues and as percentage to total market) of companies in market categories and geographies tracked. The data is rounded off to the nearest decimal places.

SAMPLEAppendix




12.2 Research Methodology GlobalData’s dedicated Research and Analysis Teams consists of qualified professionals with experience in marketing, market research, consulting background in the medical devices industry and advanced statistical expertise.

GlobalData adheres to the Codes of Practice of the Market Research Society (www.mrs.org.uk) and the Strategic and Competitive Intelligence Professionals (www.scip.org).

All GlobalData databases are continuously updated and revised. The following research methodology is followed for all databases and reports.

12.3 Secondary Research The research process begins with exhaustive secondary research on internal and external sources being carried out to source qualitative and quantitative information relating to each market.

The secondary research sources that are typically referred to include, but are not limited to:

Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings;

Industry trade journals, scientific journals and other technical literature;

Internal and external proprietary databases;

Relevant patent and regulatory databases;

National government documents, statistical databases and market reports;

Procedure registries; and

News articles, press releases and web-casts specific to the companies operating in the market.

12.4 Primary Research GlobalData conducts thousands of interviews a year with industry participants and commentators in order to validate its data and analysis. A typical research interview fulfills the following functions:

It provides first-hand information on market size, market trends, growth trends, competitive landscape and future outlook;

Helps in validating and strengthening the secondary research findings; and

Further develops the analysis team’s expertise and market understanding.

Primary research involves e-mail interactions and telephonic interviews for each market, category, segment and sub-segment across geographies.

The participants who typically take part in such a process include, but are not limited to:

SAMPLEAppendix




Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers;

Hospital stores, laboratories, pharmacies, distributors and paramedics;

Outside experts: investment bankers, valuation experts, research analysts specializing in specific medical equipment markets; and

Key opinion leaders: physicians and surgeons specializing in different therapeutic areas corresponding to different kinds of medical equipment.

12.5 Models Where no hard data is available, GlobalData uses modeling and estimates in order to produce comprehensive data sets. The following rigorous methodology is adopted:

Available hard data is cross-referenced with the following data types to produce estimates:

Demographic data on population segments;

Macro-economic indicators such as GDP, inflation rate;

Healthcare indicators such as health expenditure, physician base, healthcare infrastructure and facilities; and

Selected epidemiological and procedure statistics.

12.6 Forecasts GlobalData uses proprietary forecast models. The following four factors are utilized in the forecast models:

Historic growth rates;

Macro-indicators such as population trends and healthcare spending;

Forecast epidemiological data; and

Qualitative trend information and assumptions.

The data is then cross-checked by the expert panel.

12.7 Expert Panels GlobalData uses a panel of experts to cross verify its databases and forecasts.

GlobalData’s expert panel comprises marketing managers, product specialists, international sales managers from medical device companies; academics from research universities, KOLs from hospitals, consultants from venture capital funds and distributors/suppliers of medical equipment and supplies etc.

Historic data and forecasts are relayed to GlobalData’s Expert Panel for feedback and adjusted in accordance with their feedback.

SAMPLEAppendix




12.8 GlobalData Consulting We hope that the data and analysis in this brief will help you make informed and imaginative business decisions. If you have further requirements, GlobalData’s consulting team may be able to help you. GlobalData offers tailor-made analytical and advisory services to drive your key strategic decisions.

12.9 Currency Conversion The Currency Conversion rate is based on 2011 average rate. 1 USD =

Japan 79.801 JPY

Australia 0.966 AUD

China 6.312 CNY

India 53.612 INR

12.10 Disclaimer All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, GlobalData.

gdme0220rdb - asia-pacific drug delivery devices market ... · this report is a licensed product...

Documents